Back
Alaunos Therapeutics Stock Predictions
Sponsored
TCRT
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
20
TCRT
Alaunos Therapeutics
Last Price:
2.38
Seasonality Move:
11.94%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Alaunos Therapeutics Stock Forecast
-
Is Alaunos Therapeutics Stock Undervalued?
The current Alaunos Therapeutics [TCRT] share price is $2.40. The Score for TCRT is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - TCRT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Alaunos Therapeutics Stock Go Up Next Year?
Data Unavailable
Alaunos Therapeutics Stock Rating
Data Unavailable
Alaunos Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alaunos.com
52-Week Data
52-Week High:
32.85
52-Week Low:
1.95
Prediction Charts
Market Cap:
3.84M
Price in USD:
2.40
Volume:
35.28K
Beta:
0.96
Technical Analysis
SMA50:
2.47
SMA100:
3.35
SMA200:
9.37
52-Wk Change:
-80.75%
Stock Predictions
-
Is Alaunos Therapeutics stock public?
Yes, Alaunos Therapeutics is a publicly traded company. -
What is the Alaunos Therapeutics stock quote today?
The Alaunos Therapeutics stock price is 2.40 USD today. -
How to buy Alaunos Therapeutics stock online?
You can buy Alaunos Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-25 | 2.21 | 2.17 | 2.21 | 2.17 |
Oct-28 | 2.19 | 2.06 | 2.21 | 2.00 |
Oct-29 | 2.06 | 2.07 | 2.24 | 2.06 |
Oct-30 | 2.06 | 2.02 | 2.09 | 2.02 |
Oct-31 | 2.02 | 2.05 | 2.17 | 2.00 |
Nov-1 | 2.04 | 2.04 | 2.04 | 2.02 |
Nov-4 | 2.02 | 2.01 | 2.04 | 2.00 |
Nov-5 | 2.01 | 2.04 | 2.07 | 2.01 |
Nov-6 | 2.04 | 2.16 | 2.17 | 2.02 |
Nov-7 | 2.08 | 2.02 | 2.12 | 2.02 |
Nov-8 | 2.02 | 1.98 | 2.02 | 1.95 |
Nov-11 | 1.95 | 2.10 | 2.15 | 1.95 |
Nov-12 | 2.14 | 2.44 | 2.44 | 2.14 |
Nov-13 | 2.41 | 2.40 | 2.86 | 2.40 |
Alaunos Therapeutics Earnings
Data Unavailable
Alaunos Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $21.90 per share, and a decrease next year of $1.35 per share.
* Alaunos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.